Dr. Roberta Diaz Brinton is the Arizona Bioscience Researcher of the Year

Roberta Diaz Brinton, PhD is an internationally recognized expert in the cause and treatment of Alzheimer’s disease.  Her findings have re-shaped how the field understands the disease and unlocked the potential for new and innovative therapies to prevent and treat Alzheimer’s. Dr. Brinton will be honored by Arizona’s life science and healthcare community at the AZBio Awards on September 28, 2022 at the Phoenix Convention Center. Continue reading

Aqualung Therapeutics Receives the AZBio Fast Lane Award and Achieves Key FDA-Related Milestones

Aqualung Therapeutics, an immunotherapeutics biotech company with an anti-inflammatory therapeutic platform for serious unchecked inflammatory disorders, announced the achievement of two key FDA milestones for their therapeutic mAb ALT-100. First is the successful FDA IND submission for the indication of Acute Respiratory Distress Syndrome (ARDS). Second is the scheduling of an FDA Pre-IND type B meeting (September 14th) to discuss the targeted use of ALT-100 mAb in Radiation-induced Lung Injury and Fibrosis.Continue reading